Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma

European Journal of Ophthalmology

Volumn 18, Issue 5, 2008, Pages 765-770

  Stewart, William C ^a,b,j   Kolker, A E ^c   Sharpe, E D ^d   Day, D G ^e   Konstas, A G P ^f   Hollo G ^g   Astakhov, Y S ^h   Teus, M A ⁱ   Stewart, J A ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c Glaucoma Institute   (United States)

^d Glaucoma Consultants and Center for Eye Research   (United States)

^e Omni Eye Services   (United States)

^f AHEPA UNIVERSITY HOSPITAL   (Greece)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

ⁱ Instituto Oftalmologico de Albacete   (Spain)

^j NONE   (United States)

more..

Author keywords

Exfoliative glaucoma; Intraocular pressure; Meta analysis; Primary open angle glaucoma; Progression

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; EXFOLIATIVE GLAUCOMA; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INDIVIDUALITY; INTRAOCULAR PRESSURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 54349115915     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800517     Document Type: Article

References (25)

1. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714-20.
2. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-79.
3. Musch DC, Lichter PR, Guire KE, Standardi CL. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology 1999; 106: 653-62.
4. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498-505.
5. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-40.
6. Stewart WC, Day DG, Jenkins JN, Passmore CL, Stewart JA. Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma. J Ocul Pharmacol Ther 2006; 22: 26-33.
7. Konstas AG, Hollo G, Astakhov YS, et al. Factors Associated with long-term progression or stability in exfoliative glaucoma. Arch Ophthalmol 2004; 122: 29-33.
8. Stewart WC, Kolker AE, Sharpe ED, et al. Factors associated with long-term progression or stability in primary open-angle glaucoma. Am J Ophthalmol 2000; 130: 274-9.
9. Stewart WC, Chorak RP, Hunt HH, Sethuraman G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am J Ophthalmol 1993; 116: 176-81.
10. Mao LK, Stewart WC, Shields MB. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol 1991; 111: 51-5.
11. Ritch R. Exfoliative syndrome and occludable angles. Trans Am Ophthalmol Soc 1994; 92: 845-944.
12. Book SA. Essentials of Statistics. New York: McGraw-Hill Book Company, 1978; 122-6.
13. Swinscow TD. Statistics at square one. Br Med J 1976; 2: 291-2.
14. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Newbury Park: Sage Publications, 1986; 20-37.
15. Quigley HA, Maumenee AE. Long-term follow-up of treated open-angle glaucoma. Am J Ophthalmol 87; 1979: 519-25.
16. Kolker AE. Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 1977; 75: 539.
17. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol 1987; 65: 27-9.
18. Schulzer M, Mikelberg FS, Drance SM. Some observations on the relation between intraocular pressure reduction and the progression of glaucomatous visual loss. Br J Ophthalmol 1987; 71: 486-8.
19. Stewart WC, Sine CS, LoPresto C. Surgical versus medical management of chronic open-angle glaucoma. Am J Ophthalmol 1996; 122: 767-74.
20. Grant WM, Burke JF. Why do some people go blind from glaucoma? Ophthalmology 1982; 89: 991-8.
21. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136: 805-13.
22. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004; 122: 17-21.
23. Bengtsson B, Leske MC, Hyman L, Heijl A. Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 205-9.
24. Konstas AGP, Stewart WC, Stroman GA, Sine CS. Clinical presentation and initial treatment patterns in patients with exfoliative glaucoma versus primary open-angle glaucoma. Ophthalmic Surg Lasers 1997; 28: 111-7.
25. Konstas AG, Mantziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliative and primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 182-5.